Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study.
- Published in:
- JRSM Cardiovascular Disease, 2021, v. 10, p. 1, doi. 10.1177/2048004020982213
- By:
- Publication type:
- Article